CD105 in the progression and therapy of renal cell carcinoma

M Oladejo, HM Nguyen, L Wood - Cancer Letters, 2023 - Elsevier
Molecular biomarkers that interact with the vascular and immune compartments play an
important role in the progression of solid malignancies. CD105, which is a component of the …

[HTML][HTML] The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?

B Ayuso-Íñigo, L Méndez-García, M Pericacho… - Cancers, 2021 - mdpi.com
Simple Summary The modulation of tumor blood vessels is a great opportunity for improving
cancer therapies. Understanding the cellular and molecular players that regulate the biology …

Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens

L Alessandrini, M Ferrari, S Taboni, M Sbaraglia… - Oral Oncology, 2022 - Elsevier
Objectives The interaction between tumor cells and stroma is critical in tumorigenesis, tumor
neo–angiogenesis and cancer progression. The aims of this study were to:(i) evaluate the …

[HTML][HTML] CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients

MB Giorello, LM Martinez, FR Borzone… - Frontiers in Cell and …, 2023 - frontiersin.org
Introduction: Bone metastasis is one of the causes that mainly decrease survival in patients
with advanced breast cancer. Therefore, it is essential to find prognostic markers for the …

[HTML][HTML] Nano-resveratrol: A promising candidate for the treatment of renal toxicity induced by doxorubicin in rats through modulation of beclin-1 and mTOR

AM Alhusaini, LM Fadda, AM Alanazi… - Frontiers in …, 2022 - frontiersin.org
Background: Although doxorubicin (DXR) is one of the most used anticancer drugs, it can
cause life-threatening renal damage. There has been no effective treatment for DXR …

[HTML][HTML] Role of membrane-bound and circulating endoglin in disease

C Bernabeu, C Olivieri, E Rossi - Frontiers in Medicine, 2023 - frontiersin.org
Since its discovery and characterization in the early 1990s, a growing body of evidence
supports the involvement of endoglin in a broad range of patho-physiological conditions …

[HTML][HTML] Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

Q Huang, R Xiao, J Lu, Y Zhang, L Xu, J Gao… - Frontiers in …, 2022 - frontiersin.org
Background: Peritoneal fibrosis (PF) is an intractable complication in patients on long-term
peritoneal dialysis (PD). Transforming growth factor-β (TGF-β) is a key pro-fibrogenic factor …

Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis

T González-Muñoz, A Di Giannatale… - Clinical Cancer …, 2023 - AACR
Purpose: Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive soft-
tissue sarcomas that lack effective treatments, underscoring the urgent need to uncover …

Downregulation of stromal syntenin sustains AML development

R Leblanc, R Ghossoub, A Goubard… - EMBO Molecular …, 2023 - embopress.org
The crosstalk between cancer and stromal cells plays a critical role in tumor progression.
Syntenin is a small scaffold protein involved in the regulation of intercellular communication …

[HTML][HTML] MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer

M Iida, BE Crossman, KL Kostecki, CE Glitchev… - International Journal of …, 2024 - mdpi.com
Triple-negative breast cancer (TNBC) is characterized by the absence of the estrogen
receptor, progesterone receptor, and receptor tyrosine kinase HER2 expression. Due to the …